SAN DIEGO--(BUSINESS WIRE)--Jan. 24, 2006--Cytori Therapeutics, Inc. (NASDAQ:CYTX)(Frankfurt:XMPA) announced today it has received the CE Mark for its Celution(TM) System. This approval is the first CE Mark given for a device that can process adult stem cells from adipose (fat) tissue. By achieving this regulatory approval, the Company will receive an $11.0 million milestone payment, for consideration of development activities undertaken by Cytori, from the Olympus-Cytori Joint Venture, which was formed in November 2005 as part of Cytori’s regenerative medicine collaboration with Olympus Corporation.